Project Grant 2136439

Award Date 12/15/21
Completion Date 7/31/22
Dollars Obligated $256K
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Spokane, WA 99202, USA
Similar Awards
This SBIR Phase II Cooperative Agreement award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $983,137.00 to Quadralynx Inc. to develop a biofeedback system for adults with Parkinson's disease and other communicative disorders. The project aims to create a device and associated software to detect and report on pathological speech in adults' natural environments, with the goal of improving their quality of life,...
The National Science Foundation (NSF) awarded a Project Grant of $273,915 to Brave Virtual Worlds Inc., a for-profit small disadvantaged business, under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program. The grant aims to develop a biofeedback system that combines wearable sensors, real-time data capture, and immersive virtual reality visualization to enhance the understanding of joint angles and movement patterns. The project involves designing and refining the...
Neurodyne, Inc. received a $275,648 National Science Foundation Project Grant under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop an Analog Front End (AFE) platform for lightweight, long-term cortical monitoring. The grant period runs from February 15, 2021 through May 31, 2022. The NSF Technology, Innovation, and Partnerships program seeks to advance science and engineering research and innovation leading to breakthrough technologies as well as solutions to...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Brainstorm Therapeutics, Inc. aims to develop and validate a novel Parkinson's disease drug discovery platform using patient-derived midbrain organoids. The platform will guide therapeutic candidate identification, patient selection, and trial endpoint refinement to accelerate the development of effective disease-modifying Parkinson's treatments. Key innovations...
Neurotechr3 Inc. received a $276,000 STTR Phase I Project Grant award from the National Science Foundation on May 1, 2021 to develop a customized upper extremity telerehabilitation solution. The solution will feature remote therapist interaction and dynamic motor recovery feedback for stroke patients. The award is funded under the NSF Directorate for Engineering's Engineering program (CFDA 47.041) to improve quality of life and economic strength through innovative engineering research and...
Lifespan Digital Health LLC was awarded a $255,409 Project Grant from the National Science Foundation under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop bio-behavioral technology and provide mental health services. Specifically, the company will use predictive algorithms, wearable technology, and peripheral autonomic biofeedback to provide timely data and enable mental health professionals to treat students. This innovative approach aims to address the...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award for $295,000 will support the development of a bi-directional brain-computer interface (BCI) system by In Virtualis LLC, a woman-owned small business based in Mercer Island, WA. The goal is to create a Unity-based extended reality (XR) platform that integrates advanced AI, neural devices, and virtual/augmented reality technologies to restore functional independence for individuals...
The National Science Foundation (NSF) awarded a $549,999 Project Grant under its Technology, Innovation, and Partnerships (CFDA 47.084) program to the University of Delaware. The grant, entitled "Using Textile-Based Wearable Sensors Coated with Nanocomposites for Virtual Health and Physical Rehabilitation," aims to develop innovative wearable sensors that can detect and capture human movement kinematics and kinetics. These sensors have the potential to allow physical therapists and...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $305,000 to Sensvita Inc. aims to develop a non-invasive radiofrequency sensing technology for home-based monitoring of heart and lung function. The proposed system uses advanced sensing methods to measure critical physiological parameters without the need for skin contact or maintenance, improving the convenience, scalability, and accuracy of existing methods. Key research...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $274,976 to Ecate LLC aims to develop a novel intraspinal stimulator system to restore sensation and volitional motor control in spinal cord injury patients. The project will fabricate nanopatterned stimulating electrodes coupled with custom CMOS chips to deliver spatially selective electrical stimulation to the spinal cord. This closed-loop neural interface system is intended...

The National Science Foundation awarded Quadralynx Inc. a $255,750 Project Grant under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a biofeedback system for adults with Parkinson's disease. The grant period runs from December 15, 2021 through July 31, 2022 in Spokane, Washington. Under this award, Quadralynx will deliver a biofeedback system utilizing sensors and software to help adults with Parkinson's disease improve motor function through interactive exercises and therapies. The NSF Technology, Innovation, and Partnerships program seeks to advance science and engineering research leading to breakthrough technologies and solutions to national challenges.

Generated 1/7/24, 3:32 AM